Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Makes the body more sensitive to insulin. | First-choice tablet for type 2 diabetes. |
| Body system | Diabetes & Weight | Diabetes & Weight |
| Drug class | Thiazolidinediones | Biguanides |
| Supply | Prescription only | Prescription onlyWHO essential medicine |
| Main uses | Type 2 diabetes, Fatty liver inflammation (MASH, off-label) | Type 2 diabetes, Prediabetes (some countries), Gestational diabetes, Polycystic ovary syndrome (off-label) |
| How it works | Helps your muscles and fat respond to insulin. | Makes your liver release less sugar and helps your body respond to insulin. |
| Starts working | — | Blood sugar improves over 1–2 weeks |
| Half-life | 3–7 hours (metabolites 16–24 hours) | About 6 hours |
| Typical adult dose | 15–45 mg once a day. | Start 500 mg once or twice a day with meals; increase gradually to 1.5–2 g a day (max 2.55–3 g). |
| Forms | Tablet, Combination tablets | Tablet, Modified-release tablet, Oral solution, Combination tablets |
| Common side effects | Weight gain, Fluid retention, Headache | Diarrhoea, Nausea, Stomach pain, Metallic taste, Loss of appetite |
| Serious side effects | Heart failure, Bone fractures, Bladder cancer (small possible increase), Macular swelling | Lactic acidosis (very rare, mainly with severe kidney failure or acute illness), Vitamin B12 deficiency with long-term use |
| Don't take if | — | Severe kidney impairment (eGFR below 30); Acute illness with dehydration, sepsis or shock; Before and after iodinated contrast scans in at-risk patients; Heavy alcohol use or liver disease |
| Alcohol | — | Best to limit. Heavy drinking raises the risk of lactic acidosis and low blood sugar. |
| Pregnancy | Usually avoidedNot recommended. | Generally considered safeWidely used for gestational and type 2 diabetes in pregnancy. |
| Breastfeeding | — | Generally considered safeConsidered acceptable. |
| In use since | 1999 | 1957 |
| Brand names | United States: ActosUnited Kingdom: ActosIndia: Pioz, Piosys | United States: Glucophage, GlumetzaUnited Kingdom: Glucophage, Sukkarto SRIndia: Glycomet, Glyciphage, Obimet |
| Legal status | — | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | A10BG03 | A10BA02 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker